Background
Dr. Kamath is a board-certified neuropsychologist and a core faculty member in the Division of Medical Psychology in the Department of Psychiatry and Behavioral Sciences. She received her bachelor's degree in Psychology from Duke University. She subsequently completed her doctoral degree in clinical psychology at the University of Central Florida, a neuropsychology pre-doctoral internship at Dartmouth-Hitchcock Medical Center, and a clinical neuropsychology postdoctoral fellowship at the University of Pennsylvania.
Dr. Kamath was a Johns Hopkins KL2 Clinical Research Scholar and now serves as co-primary investigator on grants funded by the National Institute of Aging (R01AG064093) and National Institute of Neurological Disorders and Stroke (R01NS108452). She has also received funding from APA Division 40 and the Mid-Atlantic Nutrition Obesity Research Center.
Her research program represents a multi-modal investigation of the clinical and neurobiological aspects of chemosensory dysfunction in neuropsychiatric and neurodegenerative diseases. Her clinical research populations of interest include schizophrenia, frontotemporal dementia, Parkinson's disease, and Alzheimer's disease. Her lab employs a range of neuroscientific methods, including olfactory and gustatory psychophysical measures, measures of decision making, traditional neuropsychological assessment, air-dilution olfactometry, and structural and functional neuroimaging at 7T.
Dr. Kamath's clinical expertise is in the evaluation of older adults with suspected neuropsychiatric or neurodegenerative disease. She currently serves as the primary neuropsychologist for the Frontotemporal Dementia (FTD) and Young-Onset Dementias Clinic as well as the Neuromodulation and Advanced Therapies Clinic in the Johns Hopkins Parkinson's Disease and Movement Disorder Center.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Comments